Probio Technology
PrivateLast Round
Series C
Jan 17, 2023
Est. Valuation
$879.77M
Total Funding Raised
$411.3M
Company Overview
Probio Technology is a biotechnology company specializing in gene synthesis technology that accelerates the development of therapeutic antibodies and gene therapy products through an integrated platform for gene and cell therapy development and biologics discovery services.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Probio Technology Comps
Public and private peers based on sector, stage, and business model.
Probio Technology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 17, 2023 | ||||
| Series B | Jul 6, 2022 | ||||
| Series A | Sep 5, 2021 |
Probio Technology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Highlight Capital | Series C |
| Legend Capital | Series C |
Probio Technology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Probio Technology's valuation, stock price, and market status.
